Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer - PubMed
- ️Sun Jan 01 1995
Comparative Study
. 1995 Mar 1;55(5):1129-38.
Affiliations
- PMID: 7866999
Comparative Study
Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer
M F Di Renzo et al. Cancer Res. 1995.
Abstract
The c-MET oncogene encodes the receptor for hepatocyte growth factor (HGF) scatter factor, a multifunctional cytokine able to mediate morphogenesis as well as invasive growth of epithelial cells. The c-MET-encoded receptor is detectable only at low levels in the normal human exocrine pancreas, but it is up-regulated in the majority of pancreatic ductal adenocarcinomas. The c-MET-encoded HGF receptor is also overexpressed in a proportion of the panel of 31 human pancreatic cancer cell lines examined, which have a range of different growth properties and degrees of differentiation. In most cases the HGF receptor found in the malignant cells has features of the normal receptor. When added to pancreatic cancer cell lines, HGF triggers receptor phosphorylation and stimulates cells to move and proliferate. In overexpressing cell lines, the Met/HGF receptor is phosphorylated in the absence of endogenously produced or exogenously added ligand. These data suggest that the Met/HGF receptor may be involved in the growth and behavior of pancreatic cancer and may contribute to the ductal phenotype of these tumors.
Similar articles
-
Anastasi S, Giordano S, Sthandier O, Gambarotta G, Maione R, Comoglio P, Amati P. Anastasi S, et al. J Cell Biol. 1997 Jun 2;137(5):1057-68. doi: 10.1083/jcb.137.5.1057. J Cell Biol. 1997. PMID: 9166406 Free PMC article.
-
Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini P, Cremona O, Campanacci M, Comoglio PM. Ferracini R, et al. Oncogene. 1995 Feb 16;10(4):739-49. Oncogene. 1995. PMID: 7862451
-
Gherardi E, Sharpe M, Lane K, Sirulnik A, Stoker M. Gherardi E, et al. Symp Soc Exp Biol. 1993;47:163-81. Symp Soc Exp Biol. 1993. PMID: 8165564 Review.
Cited by
-
Church KJ, Vanderwerff BR, Riggers RR, McMicheal MD, Mateo-Victoriano B, Sukumar SR, Harding JW. Church KJ, et al. Anticancer Drugs. 2016 Sep;27(8):766-79. doi: 10.1097/CAD.0000000000000390. Anticancer Drugs. 2016. PMID: 27314431 Free PMC article.
-
Tsutsumi M, Kadomatsu K, Tsujiuchi T, Sakitani H, Ikematsu S, Kubozoe T, Yoshimoto M, Muramatsu T, Sakuma S, Konishi Y. Tsutsumi M, et al. Jpn J Cancer Res. 2000 Oct;91(10):979-86. doi: 10.1111/j.1349-7006.2000.tb00874.x. Jpn J Cancer Res. 2000. PMID: 11050467 Free PMC article.
-
Osada S, Carr BI. Osada S, et al. Jpn J Cancer Res. 2000 Dec;91(12):1250-7. doi: 10.1111/j.1349-7006.2000.tb00911.x. Jpn J Cancer Res. 2000. PMID: 11123423 Free PMC article.
-
Weber JC, Schneider A, Rohr S, Nakano H, Bachellier P, Méchine A, Hamel G, Kanor M, Chenard MP, Gaub MP, Oudet P, Meyer C, Jaeck D. Weber JC, et al. Ann Surg. 2001 Dec;234(6):795-802; discussion 802-3. doi: 10.1097/00000658-200112000-00011. Ann Surg. 2001. PMID: 11729386 Free PMC article.
-
Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.
Mihaljevic AL, Michalski CW, Friess H, Kleeff J. Mihaljevic AL, et al. Langenbecks Arch Surg. 2010 Apr;395(4):295-308. doi: 10.1007/s00423-010-0622-5. Epub 2010 Mar 18. Langenbecks Arch Surg. 2010. PMID: 20237938 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous